Overview
Cognito Therapeutics develops non-invasive neuromodulation devices designed to modulate brain activity and support brain health through white matter preservation and brain plasticity enhancement. The company focuses on medical device solutions for neurodegenerative diseases, including Alzheimer's disease, with a mission to support brain function and cognitive health.
More in Neurotechnology
Latest industry news
Tianjin University Unveils a 3-Gram Non-Invasive BCI That Disappears Into Your Hair
2026-10-04 · Research
Neuralink Pretrained on 50,000 Hours of Unlabeled Brain Data — and the Implications Are Enormous
2026-10-03 · Research
BlueWind Medical Wins Category I CPT Code for Subfascial Tibial Neuromodulation
2026-10-02 · Policy
Neurable One Brings Brain-Computer Interface Technology to Consumer Wireless Headphones
2026-10-01 · Product
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →